Results 101 to 110 of about 178,155 (246)

Characteristics and outcome of critically ill patients with 2009 H1N1 influenza infection in Syria

Avicenna Journal of Medicine, 2012
Objectives: To describe the epidemiologic characteristics, clinical features, and outcome of severe cases of 2009 H1N1 influenza A infections who were admitted to the intensive care units (ICUs) in Damascus, Syria. Materials and Methods: Retrospectively,
Reem Alsadat, Abdulrahman Dakak, Mouna Mazlooms, Ghasan Ghadhban, Shadi Fattoom, Ibrahim Betelmal, Nabil Abouchala, Mazen Kherallah   +7 more
doaj   +1 more source

Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.
ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode, Mitchel C. Rothholz, Stephan L. Foster, Erica R. Brody, John D. Gräbenstein   +4 more
wiley   +1 more source

Organoids: From Bench to Bedside Applications

MedComm, Volume 7, Issue 6, June 2026.
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li, Rui Cao, Maochen Li, Zichao Tian, Huahao Fan, Bixia Hong, Xiaojuan Liu   +6 more
wiley   +1 more source

Integrating One Health Into Health Systems: A Systematic Review and Narrative Synthesis of Implementation Challenges, Opportunities and Strategic Directions

Public Health Challenges, Volume 5, Issue 2, June 2026.
This systematic review synthesizes global evidence on the integration of One Health into national health systems. It identifies key system‐level barriers, including governance fragmentation, financing constraints, workforce limitations, and policy gaps, alongside emerging opportunities such as institutional support and multisectoral collaboration.
Md. Shahidul Islam, Nusrat Jahan, Daniel Teshome Gebeyehu   +2 more
wiley   +1 more source

When Being in the Minority Feels Threatening: Social Identity and the Reinforcement of Anti‐Vaccination Attitudes

Scandinavian Journal of Psychology, Volume 67, Issue 3, Page 874-890, June 2026.
ABSTRACT The present research aims to contribute to the understanding of anti‐vaccination attitudes. We do this by analyzing the role of social identity and intergroup threat. Drawing on intergroup threat theory, we hypothesize that being informed that the general population is positive toward vaccines may be perceived as threatening to individuals ...
Emma A. Renström, Hanna Bäck, Amanda Remsö   +2 more
wiley   +1 more source

How Does Influenza A (H1N1) Infection Proceed in Allogeneic Stem Cell Transplantation Recipients?

Turkish Journal of Hematology, 2012
Clinical course of H1N1 infection in Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) patients is contraversial. We report three AHSCT patients who were infected with Influenza A/H1N1 infection. All of the patients were diagnosed with different
Sinem Civriz Bozdağ, Gülden Bozkurt, Pervin Topcuoglu, Alpay Azap, Muhit Özcan, Nahide Konuk, Önder Arslan   +6 more
doaj   +1 more source

The Global Ability to Respond: Applying SARS Knowledge to H1N1 and Beyond [PDF]

, 2013
Influenza outbreaks may be alarming, but they are nothing new in the 21st century. At this point, the various strains of influenza have broken into cities and homes, acted as silent killers by causing fear, death and destruction, and spreading ...
Drees, Meaghan
core   +1 more source

A Retrospective Cross‐Sectional Study (2009–2023): Exploring Influenza A(H1N1)pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target Groups

Zoonoses and Public Health, Volume 73, Issue 4, Page 336-347, June 2026.
ABSTRACT Introduction Swine may act as ‘epidemiological bridges’ and reservoirs for the emergence of novel zoonotic influenza viruses with pandemic potential. While bidirectional exchange of influenza A viruses at the swine–human interface is well recognised, data on the extent of interspecies transmission are limited.
Solveig Jore, Ragnhild Tønnessen, Carl Andreas Grøntvedt, Kjersti Rydland, Anna Germundsson Hauge, Olav Hungnes, Anja Bråthen Kristoffersen, Even Fossum   +7 more
wiley   +1 more source

Reassortant Eurasian Avian-Like Influenza A(H1N1) Virus from a Severely Ill Child, Hunan Province, China, 2015

Emerging Infectious Diseases, 2016
In 2015, a novel influenza A(H1N1) virus was isolated from a boy in China who had severe pneumonia. The virus was a genetic reassortant of Eurasian avian-like influenza A(H1N1) (EA-H1N1) virus.
Wenfei Zhu, Hong Zhang, Xingyu Xiang, Lili Zhong, Lei Yang, Junfeng Guo, Yiran Xie, Fangcai Li, Zhihong Deng, Hong Feng, Yiwei Huang, Shixiong Hu, Xin Xu, Xiaohui Zou, Xiaodan Li, Tian Bai, Yongkun Chen, Zi Li, Junhua Li, Yuelong Shu   +19 more
doaj   +1 more source

MVP Inhibits Influenza A Virus‐Induced Ferroptosis by Targeting IRF1 and Increasing FSP1 Activity

Advanced Science, Volume 13, Issue 26, 8 May 2026.
During IAV infection, MVP inhibits IRF1 polyubiquitination, thereby relieving IRF1‐mediated transcriptional inhibition of FSP1. Consequently, this leads to an upregulation of FSP1 expression, thereby reinforcing the inhibition of ferroptosis. In addition, the MVP can promote myristoylation and ubiquitination of FSP1, enabling its membrane localization ...
Yingbo Chen, Paili Lin, Yongfang Xia, Zhiqiang Liu, Zilu Cheng, Qingmei Zhu, Shiqi Wan, Xiaoyu Chen, Haiyan Bao, Renbo Qiao, Gechang Zhong, Ying Zhu, Shi Liu   +12 more
wiley   +1 more source